Altre lingue Amneal Pharmaceuticals, Inc.

Azioni

AMRX

US03168L1052

Tempo reale stimato Cboe BZX Altri mercati azionari 20:11:22 30/04/2024			Variaz. 5gg	Var. 1 gen.
6,025 ^USD	+1,43%		+11,20%	-1,07%

24/04	Amneal Pharmaceuticals ha ottenuto l'autorizzazione dalla FDA a vendere la versione generica dello spray nasale per il trattamento dell'overdose da oppioidi -- Azioni in rialzo	MT
24/04	Amneal annuncia l'approvazione da parte della FDA degli Stati Uniti dello spray nasale di Naloxone cloridrato da banco per il trattamento di emergenza di un'overdose da oppioidi	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

California is joining with a New Jersey company to buy a generic opioid overdose reversal drug	29/04
Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	24/04
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray	24/04
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose	24/04
Amneal Announces U.S. FDA Approval of Over-The-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose	24/04
Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US	18/04
Amneal Pharmaceuticals Announces Launch of Pemetrexed Injection, 100mg/10 Mg/10 Mg/50 Mg/Ll	18/04
Amneal Launches PEMRYDI RTU, the First Ready-to-Use Version of Important Oncology Injectable Medicine	17/04
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine	16/04
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says	12/04
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds	12/04
Amneal to Report First Quarter 2024 Results on May 3, 2024	10/04
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision	08/04
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals	08/04
North American Morning Briefing : Inflation Data, -2-	08/04
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024	28/03
Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, due to the potential for some bottles to be super potent which may be harmful	28/03
Amneal Pharmaceuticals : LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, due to the potential for some bottles to be super potent which may be harmful.	27/03
Amneal Pharma Gets FDA Nod for Infection Fighting Drug Combination	25/03
Amneal Pharmaceuticals Receives FDA Approval for Ear Infection Treatment	25/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Amneal Pharmaceuticals, Inc.

Azioni

AMRX

US03168L1052

Altre lingue

Filtri